Alcon Expands Foothold in Eye Sector with $770 Million Aerie Pharmaceuticals Purchase
In order to gain access to Aerie Pharmaceuticals’ open-angle glaucoma and ocular hypertension medications, Alcon announced that it will acquire the company…
In order to gain access to Aerie Pharmaceuticals’ open-angle glaucoma and ocular hypertension medications, Alcon announced that it will acquire the company…